Navigation Links
Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Date:1/13/2009

HOPKINTON, Mass., Jan. 13 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE), today announced that on January 8, 2009 it entered into a securities purchase agreement (the "Agreement") with Robert Gipson for the private placement of 1,000,000 shares of common stock of the Company at a purchase price of $1.00 per share. The financing resulted in total gross proceeds of $1 million. In connection with the Agreement, Mr. Gipson agreed to the cancellation of a warrant previously issued to him to purchase 543,478 shares of common stock of the Company at a purchase price of $1.84 per share. The Company intends to use the net proceeds from this private placement to fund its research and development programs and otherwise for general corporate purposes.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO )

In connection with the Agreement, the Company issued an additional 456,522 shares of its common stock to Mr. Gipson pursuant to a Letter Agreement (the "Letter Agreement") between the Company and Mr. Gipson dated November 20, 2008. The Letter Agreement provided that if the Company sold shares of its common stock at a price below $1.84, subject to certain exceptions, prior to December 31, 2009, Mr. Gipson would be entitled to receive, for no additional consideration, additional shares of common stock and warrants in accordance with a pre-determined formula. Under the Agreement, Mr. Gipson has waived his right to additional warrants.

The securities offered and sold by Alseres in this private placement have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Ex
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
2. Alseres Pharmaceuticals, Inc. Raises $5 Million
3. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
4. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
5. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
6. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
9. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
10. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
11. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... With a larger, brighter interface, ... Cole-Parmer® Digital Gear Pump Drive for Micropump® ... for automated process applications. , Simply set time ... count function counts down and displays batches completed ... dispensed across multiple cycles. View the four operating ...
(Date:7/21/2014)... 2014 ResearchMoz presents this ... USA Cancer Biomaker Market to 2018 ... ResearchMoz presents this most up-to-date research on Global ... Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, ... GLOBAL & USA ...
(Date:7/18/2014)... 2014 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... and operating results on Tuesday, August 5, 2014, before ... a conference call and simultaneous webcast at 8:30 AM ... InformationTo access this call, dial (888) 660-6127 (U.S.) or ... be accessed from the ,Events and Presentations, page of ...
(Date:7/18/2014)... , July 18, 2014  Neurotrope, Inc. (OTCQB: NTRP) ... of Directors appointed Co-Chairmen Charles S. Ramat ... on an interim basis, effective immediately. Messrs. Ramat and ... no longer Chief Executive Officer of Neurotrope Bioscience, Inc., ... and whose employment agreement with Neurotrope Bioscience Inc. terminated ...
Breaking Biology Technology:New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 2Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 4
... China,Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," ... companies in the,People,s Republic of China ("PRC"), today ... was approved for quotation on the Over-the-Counter,Bulletin Board ... (FINRA)., "We are pleased to have our ...
... 4 Vical Incorporated,(Nasdaq: VICL ) today ... Executive Officer, will participate in a roundtable discussion,"An ... Engaging in,Global Health Product Development," and present an ... needs on Tuesday,March 11, at the Biotechnology Industry ...
... SAN DIEGO, March 4 SGX Pharmaceuticals,(Nasdaq: ... fourth quarter and,full year 2007 on Wednesday, March ... live conference call and webcast at 8:00 a.m. ... and Todd Myers, Chief,Financial Officer, will host the ...
Cached Biology Technology:China Biologic Products Commences Trading on OTC Bulletin Board 2Vical to Present at BIO and BVGH Global Health Partnering Event 2Vical to Present at BIO and BVGH Global Health Partnering Event 3SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results 2
(Date:7/21/2014)... A team of University of California, Riverside Bourns College of ... the grates of a backyard grill reduces by 70 percent ... The one-eighth inch thick steel carbon plate with an insulated ... a slit into the grill to allow the plate to ... by grill manufacturers who could sell new grills with the ...
(Date:7/21/2014)... Matriaux Tlcommunications Research Centre successfully imaged a chemical ... exceeding that obtained to date using microscopes. The ... a molecular movie of how an acetylene molecule ... was recently published in the scientific journal ... developed combines multiphoton ionization and Coulomb explosion imaging. ...
(Date:7/21/2014)... CAEating meat contributes to climate change, due to greenhouse ... emissions are on the rise and that beef cattle ... other types of animals. It is published by ... most-prevalent gas when it comes to climate change. It ... comprises the greatest portion of greenhouse gas totals. But ...
Breaking Biology News(10 mins):Catching grease to cut grill pollution 2Climate: Meat turns up the heat 2
... DURHAM, N.C. -- A magnetic separation technique developed by ... Purdue University makes it relatively simple to sort through ... the end of this sentence. The method ... testing, according to the researchers. For example, specially coated ...
... Elsevier, a leading publisher of scientific, technical and ... (NESLi2) have agreed to a four-year license for ScienceDirect, ... information. Key to the agreement is the high ... a product of the UKs Joint Information Systems Committee ...
... Ohio State University geologists and their colleagues have uncovered ... oxygen-rich atmosphere similar to the one we breathe today. ... crust initiated a kind of reverse-greenhouse effect 500 million ... plankton blooms, and sent a burst of oxygen into ...
Cached Biology News:New magnetic separation technique might detect multiple pathogens at once 2Researchers find origin of 'breathable' atmosphere half a billion years ago 2Researchers find origin of 'breathable' atmosphere half a billion years ago 3Researchers find origin of 'breathable' atmosphere half a billion years ago 4
... Neural Stem Cell Functional Identification Kit ... can be used for the short-term ... and the induction of NSCs into ... antibody panel consisting of mouse anti-human ...
Anti-Mouse MIP-1g, Biotin (Polyclonal) (rabbit IgG)...
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
Request Info...
Biology Products: